|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09997 KANGJI MEDICAL
Nominal 
5.900 +0.110 (+1.900%) | 2024/06 - Interim RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 419,615 | 319,313 | 435,749 | 221,044 |
| Net Cash from / (used in) Investing Activities | -- | (391,696) | (369,983) | (160,093) | (610,978) |
| Net Cash from / (used in) Financing Activities | -- | (243,532) | (472,792) | (97,610) | 2,151,811 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | (215,613) | (523,462) | 178,046 | 1,761,877 |
| Cash & Cash Equivalents at beginning of period | -- | 1,738,963 | 2,177,833 | 2,034,337 | 469,336 |
| Effect of Foreign Exchange Rate Changes | -- | (2,953) | 84,592 | (34,550) | (196,876) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,520,397 | 1,738,963 | 2,177,833 | 2,034,337 |
| Remarks: | Real time quote last updated: 01/11/2024 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 285,847,000 |
| %Change | 11.895% |
| EPS / (LPS) | RMB 0.244 |
| NBV Per Share (¥) | RMB 1.945 |